HIV-1 epidemic in Warao Amerindians from Venezuela: spatial phylodynamics and epidemiological patterns

AIDS. 2013 Jul 17;27(11):1783-91. doi: 10.1097/QAD.0b013e3283601bdb.

Abstract

Objectives: We previously reported HIV-1 infection in Warao Amerindians from Venezuela. The aim of this study was to evaluate the extent and the dynamic of HIV-1 dissemination in eight Warao communities.

Design and setting: HIV-1 infection was evaluated in 576 Warao Amerindians from the Orinoco Delta. Partial HIV-1 pol sequences were analyzed to reconstruct the spatiotemporal and demographic dynamics of the epidemic.

Results: HIV-1 antibodies were present in 9.55% of Warao Amerindians, ranging from 0 to 22%. A significantly higher prevalence was found in men (15.6%) compared with women (2.6%), reaching up to 35% in men from one community. All but one isolates were classified as subtype B. Warao's HIV-1 subtype-B epidemic resulted from a single viral introduction at around the early 2000s. After an initial phase of slow growth, the subtype B started to spread at a fast rate (0.8/year) following two major routes of migration within the communities.

Conclusion: A dramatic high prevalence was documented in almost all the communities of Warao Amerindians from the Orinoco Delta tested for HIV-1 infection. This epidemic resulted from the dissemination of a single HIV-1 subtype B founder strain introduced about 10 years ago and its size is probably doubling every year, creating a situation that can be devastating for this vulnerable Amerindian group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Cluster Analysis
  • Epidemics*
  • Female
  • Genotype
  • HIV Infections / epidemiology*
  • HIV Infections / virology
  • HIV-1 / classification*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification*
  • Humans
  • Indians, South American*
  • Male
  • Middle Aged
  • Molecular Epidemiology
  • Molecular Sequence Data
  • Phylogeography
  • Prevalence
  • Sequence Analysis, DNA
  • Venezuela / epidemiology
  • Young Adult
  • pol Gene Products, Human Immunodeficiency Virus / genetics

Substances

  • pol Gene Products, Human Immunodeficiency Virus

Associated data

  • GENBANK/KC133213
  • GENBANK/KC133214
  • GENBANK/KC133215
  • GENBANK/KC133216
  • GENBANK/KC133217
  • GENBANK/KC133218
  • GENBANK/KC133219
  • GENBANK/KC133220
  • GENBANK/KC133221
  • GENBANK/KC133222
  • GENBANK/KC133223
  • GENBANK/KC133224
  • GENBANK/KC133225
  • GENBANK/KC133226
  • GENBANK/KC133227
  • GENBANK/KC133228
  • GENBANK/KC133229
  • GENBANK/KC133230
  • GENBANK/KC133231
  • GENBANK/KC133232
  • GENBANK/KC133233
  • GENBANK/KC133234
  • GENBANK/KC133235
  • GENBANK/KC133236
  • GENBANK/KC133237
  • GENBANK/KC133238
  • GENBANK/KC133239
  • GENBANK/KC133240
  • GENBANK/KC133241
  • GENBANK/KC133242
  • GENBANK/KC133243
  • GENBANK/KC133244
  • GENBANK/KC133245
  • GENBANK/KC133246
  • GENBANK/KC133247
  • GENBANK/KC133248
  • GENBANK/KC133249
  • GENBANK/KC133250
  • GENBANK/KC133251
  • GENBANK/KC133252
  • GENBANK/KC133253
  • GENBANK/KC133254
  • GENBANK/KC133255
  • GENBANK/KC133256
  • GENBANK/KC133257
  • GENBANK/KC133258
  • GENBANK/KC133259
  • GENBANK/KC133260
  • GENBANK/KC133261
  • GENBANK/KC133262
  • GENBANK/KC133263
  • GENBANK/KC133264
  • GENBANK/KC133265